UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis

Advances in therapy, 2008-09, Vol.25 (9), p.858-870

Luchs, Jodi

2008

Volltextzugriff (PDF)

Azithromycin in DuraSite for the treatment of blepharitis

Clinical ophthalmology (Auckland, N.Z.), 2010-01, Vol.4, p.681-688

Luchs, Jodi

2010

Volltextzugriff (PDF)

Dysfunctional tear syndrome: dry eye disease and associated tear film disorders – new strategies for diagnosis and treatment

Current opinion in ophthalmology, 2017-01, Vol.27 Suppl 1 (SUPPLEMENT 1), p.3-47

2017

Volltextzugriff (PDF)

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease

Clinical ophthalmology (Auckland, N.Z.), 2018-01, Vol.12, p.1921-1929

2018

Volltextzugriff (PDF)

Safety and efficacy of amniotic cytokine extract in the treatment of dry eye disease

Clinical ophthalmology (Auckland, N.Z.), 2019-05, Vol.13, p.887-894

2019

Volltextzugriff (PDF)

Corneal Cross-linking: Epi-On vs. Epi-Off Current Protocols, Pros, and Cons

Current ophthalmology reports, 2020-09, Vol.8 (3), p.99-103

2020

Volltextzugriff (PDF)

Effect of OTX-101 in Patients with Dry Eye Disease at Day 14 of Treatment: Ocular Surface Endpoint Results from the Phase 2b/3 Clinical Trial

Clinical ophthalmology (Auckland, N.Z.), 2022-01, Vol.16, p.4145-4151

2022

Volltextzugriff (PDF)

Changes in preoperative corneal measurements following same-day intraocular pressure testing with rebound tonometry

Therapeutic advances in ophthalmology, 2020-01, Vol.12, p.2515841419892070-2515841419892070

2020

Volltextzugriff (PDF)

Sensitivity and specificity of the AdenoPlus test for diagnosing adenoviral conjunctivitis

JAMA ophthalmology, 2013-01, Vol.131 (1), p.17

2013

Volltextzugriff (PDF)

The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren’s Syndrome Diagnosis

Advances in therapy, 2017-04, Vol.34 (4), p.799-812

2017

Volltextzugriff (PDF)

Efficacy of hydroxypropyl cellulose ophthalmic inserts (LACRISERT) in subsets of patients with dry eye syndrome: findings from a patient registry

Cornea, 2010-12, Vol.29 (12), p.1417-1427

2010

Volltextzugriff (PDF)

Late-onset fungal interface keratitis following endothelial keratoplasty with positive donor fungal culture

American journal of ophthalmology case reports, 2020-06, Vol.18, p.100707, Article 100707

2020

Volltextzugriff (PDF)

Lifitegrast for the Treatment of Dry Eye Disease

Ophthalmology (Rochester, Minn.), 2017-01, Vol.124 (1), p.53-60

2017

Volltextzugriff (PDF)

Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs

Ophthalmology (Rochester, Minn.), 2001-05, Vol.108 (5), p.936-944

2001

Volltextzugriff (PDF)

Visual Outcome and Bacterial Sensitivity After Methicillin-Resistant Staphylococcus aureus– Associated Acute Endophthalmitis

American journal of ophthalmology, 2008-03, Vol.145 (3), p.413-417.e1

2008

Volltextzugriff (PDF)

Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease

Ophthalmology (Rochester, Minn.), 2015-12, Vol.122 (12), p.2423-2431

2015

Volltextzugriff (PDF)

Lifitegrast for the Treatment of Dry Eye Disease: Results of a Phase III, Randomized, Double-Masked, Placebo-Controlled Trial (OPUS-3)

Ophthalmology (Rochester, Minn.), 2017-01, Vol.124 (1), p.53-60

2017

Volltextzugriff (PDF)

Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study

Ophthalmology (Rochester, Minn.), 2015-12, Vol.122 (12), p.2423-2431

2015

Volltextzugriff (PDF)

Efficacy and Safety of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, for the Treatment of Keratoconjunctivitis Sicca: Pooled Analysis of a Phase 2b/3 and Phase 3 Study

Eye & contact lens, 2020-01, Vol.46 Suppl 1 (1), p.S14-S19

2020

Volltextzugriff (PDF)

Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 Trial

American journal of ophthalmology, 2019-11, Vol.207, p.248-257

2019

Volltextzugriff (PDF)

Re: Keen et al.: Treatment of acute conjunctivitis in the United States and evidence of antibiotic overuse: isolated issue or a systematic problem? (Ophthalmology. 2017;124:1096-1098)

Ophthalmology (Rochester, Minn.), 2018-07, Vol.125 (7), p.e44-e45

2018

Volltextzugriff (PDF)

Managing Dry Eye Disease and Facilitating Realistic Patient Expectations: A Review and Appraisal of Current Therapies

Clinical ophthalmology (Auckland, N.Z.), 2020-01, Vol.14, p.119-126

2020

Volltextzugriff (PDF)

Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies

Cornea, 2019-10, Vol.38 (10), p.1259-1265

2019

Volltextzugriff (PDF)

Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2)

Drugs (New York, N.Y.), 2021-11, Vol.81 (17), p.2017-2033

2021

Volltextzugriff (PDF)

Phase 3 Efficacy

Clinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.14, p.129

2021

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(39)

Publikationsform

Sprache

Englisch
(47)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis

Azithromycin in DuraSite for the treatment of blepharitis

Dysfunctional tear syndrome: dry eye disease and associated tear film disorders – new strategies for diagnosis and treatment

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease

Safety and efficacy of amniotic cytokine extract in the treatment of dry eye disease

Corneal Cross-linking: Epi-On vs. Epi-Off Current Protocols, Pros, and Cons

Effect of OTX-101 in Patients with Dry Eye Disease at Day 14 of Treatment: Ocular Surface Endpoint Results from the Phase 2b/3 Clinical Trial

Changes in preoperative corneal measurements following same-day intraocular pressure testing with rebound tonometry

Sensitivity and specificity of the AdenoPlus test for diagnosing adenoviral conjunctivitis

The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren’s Syndrome Diagnosis

Efficacy of hydroxypropyl cellulose ophthalmic inserts (LACRISERT) in subsets of patients with dry eye syndrome: findings from a patient registry

Late-onset fungal interface keratitis following endothelial keratoplasty with positive donor fungal culture

Lifitegrast for the Treatment of Dry Eye Disease

Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs

Visual Outcome and Bacterial Sensitivity After Methicillin-Resistant Staphylococcus aureus– Associated Acute Endophthalmitis

Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease

Lifitegrast for the Treatment of Dry Eye Disease: Results of a Phase III, Randomized, Double-Masked, Placebo-Controlled Trial (OPUS-3)

Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study

Efficacy and Safety of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, for the Treatment of Keratoconjunctivitis Sicca: Pooled Analysis of a Phase 2b/3 and Phase 3 Study

Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 Trial

Re: Keen et al.: Treatment of acute conjunctivitis in the United States and evidence of antibiotic overuse: isolated issue or a systematic problem? (Ophthalmology. 2017;124:1096-1098)

Managing Dry Eye Disease and Facilitating Realistic Patient Expectations: A Review and Appraisal of Current Therapies

Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies

Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2)

Phase 3 Efficacy

Suchergebnisse filtern